secwatch / observer
8-K filed April 5, 2022, 7:59 PM ET ticker SCND CIK 0000087802
leadership confidence high sentiment neutral materiality 0.50

Scientific Industries announces leadership changes: Vogt resigns, Moore and Gruenes appointed

SCIENTIFIC INDUSTRIES INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Reinhard Vogt

Chairman of Scientific Bioprocessing Inc. (SBI)
SCND · SCIENTIFIC INDUSTRIES INC
Effective
2022-04-01
Successor
John A. Moore
Filed
April 5, 2022, 7:59 PM ET
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
Departed

Reinhard Vogt

Class A Director of the Board of Directors
SCND · SCIENTIFIC INDUSTRIES INC
Effective
2022-04-01
Filed
April 5, 2022, 7:59 PM ET
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
Appointed

Daniel Gruenes

Chief Executive Officer and President of Scientific Bioprocessing Inc. (SBI)
SCND · SCIENTIFIC INDUSTRIES INC
Effective
2022-04-04
Filed
April 5, 2022, 7:59 PM ET
Mr. Daniel Gruenes was elected as SBI’s new Chief Executive Officer and President
Appointed

John A. Moore

Chairman of Scientific Bioprocessing Inc. (SBI)
SCND · SCIENTIFIC INDUSTRIES INC
Effective
2022-04-04
Successor
Reinhard Vogt
Filed
April 5, 2022, 7:59 PM ET
the Company’s Board of Directors appointed Mr. John A. Moore as SBI’s Chairman

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Reinhard Vogt resigned as Chairman of Scientific Bioprocessing Inc. (SBI) at SCIENTIFIC INDUSTRIES INC.

Action
resigned
Role
Chairman of Scientific Bioprocessing Inc. (SBI)
Exact text from the filing
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Reinhard Vogt resigned as director of Scientific Bioprocessing Holdings, Inc. at SCIENTIFIC INDUSTRIES INC.

Action
resigned
Role
director of Scientific Bioprocessing Holdings, Inc.
Exact text from the filing
Mr. Vogt resigned from his positions as a Class A Director of the Company’s Board of Directors, Chairman of the Company’s indirect wholly-owned subsidiary, Scientific Bioprocessing Inc. (”SBI”), and director of the Company’s wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Gruenes was elected as Chief Executive Officer and President of Scientific Bioprocessing Inc. (SBI) at SCIENTIFIC INDUSTRIES INC.

Action
elected
Role
Chief Executive Officer and President of Scientific Bioprocessing Inc. (SBI)
Exact text from the filing
Mr. Daniel Gruenes was elected as SBI’s new Chief Executive Officer and President
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John A. Moore was appointed as Chairman of Scientific Bioprocessing Inc. (SBI) at SCIENTIFIC INDUSTRIES INC.

Action
appointed
Role
Chairman of Scientific Bioprocessing Inc. (SBI)
Exact text from the filing
the Company’s Board of Directors appointed Mr. John A. Moore as SBI’s Chairman
View on SEC.gov

SCIENTIFIC INDUSTRIES INC filing history →

Source: SEC EDGAR
accession 0001654954-22-004599
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.